CCCC vs K · rev $35.6M vs P/E 23, $29.03B cap
C4 Therapeutics Inc (CCCC) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
K does not have a complete income-statement cache yet.
CCCC currently screens at market cap $425.7M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the CCCC and K stock pages for the full models.
Not investment advice.